Published in J Virol on February 01, 1985
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A (1989) 6.32
Sequence requirements for synthetic peptide-mediated translocation to the nucleus. Mol Cell Biol (1989) 4.57
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A (1992) 4.27
Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol (1988) 3.02
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol (1993) 2.92
Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation. EMBO J (1987) 2.76
Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products. Mol Cell Biol (1987) 2.38
The release of growth arrest by microinjection of adenovirus E1A DNA. EMBO J (1985) 2.32
Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol (1995) 1.87
The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci U S A (1995) 1.77
Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol (1993) 1.75
E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol (1998) 1.75
Isolation and characterization of PEP3, a gene required for vacuolar biogenesis in Saccharomyces cerevisiae. Mol Cell Biol (1991) 1.66
Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins. EMBO J (1987) 1.61
Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc Natl Acad Sci U S A (1991) 1.54
Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. J Virol (1992) 1.54
Mapping of functional domains in adenovirus E1A proteins. Proc Natl Acad Sci U S A (1985) 1.53
Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol (2008) 1.53
Identification of a region of simian virus 40 large T antigen required for cell transformation. J Virol (1990) 1.50
Vector expression of adenovirus type 5 E1a proteins: evidence for E1a autoregulation. Mol Cell Biol (1985) 1.49
trans-dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor. Mol Cell Biol (1991) 1.39
Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains. Mol Cell Biol (1992) 1.37
Regulation of early adenovirus gene expression. Microbiol Rev (1987) 1.34
The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells. Mol Cell Biol (1988) 1.34
The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res (1996) 1.33
Adenovirus E1a ras cooperation activity is separate from its positive and negative transcription regulatory functions. Mol Cell Biol (1988) 1.30
The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells. J Virol (1991) 1.25
Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J Virol (1996) 1.24
Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis. J Virol (1996) 1.19
E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Mol Cell Biol (1993) 1.13
Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a. Mol Cell Biol (1990) 1.11
Expression and interactions of human adenovirus oncoproteins. Biochem J (1991) 1.10
Recruitment of CBP/p300, TATA-binding protein, and S8 to distinct regions at the N terminus of adenovirus E1A. J Virol (2005) 1.08
Organization of the transcriptional control region of the E1b gene of adenovirus type 5. J Virol (1988) 1.08
Immortalization of primary epithelial cells requires first- and second-exon functions of adenovirus type 5 12S. J Virol (1992) 1.06
An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter. Nucleic Acids Res (1994) 1.05
Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses. J Virol (2002) 1.05
Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J Virol (1990) 1.04
Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases. Mol Biol Cell (2001) 1.03
E1a transactivation of human HSP70 gene promoter substitution mutants is independent of the composition of upstream and TATA elements. Mol Cell Biol (1990) 1.03
In vivo association of adenovirus large E1A protein with the human mediator complex in adenovirus-infected and -transformed cells. J Virol (2002) 1.02
Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP. Nucleic Acids Res (2009) 1.01
Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation. J Virol (1992) 1.00
Rapid turnover of adenovirus E1A is determined through a co-translational mechanism that requires an aminoterminal domain. EMBO J (1988) 0.98
The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation. EMBO J (1992) 0.97
Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function. J Virol (1988) 0.97
The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J Virol (1993) 0.95
The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K. Mol Cell Biol (1996) 0.94
Characterization of a low-molecular-weight virus-associated (VA) RNA encoded by simian adenovirus type 7 which functionally can substitute for adenovirus type 5 VA RNAI. J Virol (1986) 0.88
Genetic dissection of the transactivating domain of the E1a 289R protein of adenovirus type 2. J Virol (1989) 0.87
Upstream DNA sequences determine different autoregulatory responses of the adenovirus types 5 and 3 E1A promoters. J Virol (1989) 0.85
Adenovirus type 12 E1A protein expressed in Escherichia coli is functional upon transfer by microinjection or protoplast fusion into mammalian cells. J Virol (1986) 0.85
Induction of cell cycle progression by adenovirus E1A gene 13S- and 12S-mRNA products in quiescent rat cells. Mol Cell Biol (1987) 0.84
AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain. J Virol (1998) 0.83
Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. J Virol (1994) 0.83
Differential requirement for adenovirus type 12 E1A gene products in oncogenic transformation. J Virol (1990) 0.82
In vitro analysis of the E1A-homologous sequences of RIZ. J Virol (1997) 0.82
Maintenance of cellular proliferation by adenovirus early region 1A in fibroblasts conditionally immortalized by using simian virus 40 large T antigen requires conserved region 1. Mol Cell Biol (1990) 0.81
Identification of temperature-sensitive DNA- mutants of Chinese hamster cells affected in cellular and viral DNA synthesis. Mol Cell Biol (1986) 0.81
The degradation sequence of adenovirus E1A consists of the amino-terminal tetrapeptide Met-Arg-His-Ile. Mol Cell Biol (1990) 0.80
Adenovirus E1A gene autorepression: revertants of an E1A promoter mutation encode altered E1A proteins. Proc Natl Acad Sci U S A (1987) 0.80
Requirements for E1A dependent transcription in the yeast Saccharomyces cerevisiae. BMC Mol Biol (2009) 0.79
A novel general approach to eucaryotic mutagenesis functionally identifies conserved regions within the adenovirus 13S E1A polypeptide. Mol Cell Biol (1986) 0.78
Effects of Adenovirus Type 5 E1A Isoforms on Viral Replication in Arrested Human Cells. PLoS One (2015) 0.78
Database of mutations within the adenovirus 5 E1A oncogene. Nucleic Acids Res (1998) 0.77
Functional diversity of E1A gene autoregulation among human adenoviruses. J Virol (1992) 0.76
Competitive Inhibition of Lysine Acetyltransferase 2B by a Small Motif of the Adenoviral Oncoprotein E1A. J Biol Chem (2016) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70
Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell (1977) 61.24
An efficient mRNA-dependent translation system from reticulocyte lysates. Eur J Biochem (1976) 46.42
Detection of specific RNAs or specific fragments of DNA by fractionation in gels and transfer to diazobenzyloxymethyl paper. Methods Enzymol (1979) 18.24
An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci U S A (1979) 13.21
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell (1979) 12.83
Mechanism of activation of a human oncogene. Nature (1982) 12.09
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (1982) 11.92
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell (1979) 10.95
Structure of the adenovirus 2 early mRNAs. Cell (1978) 10.54
The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell (1983) 8.19
Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spring Harb Symp Quant Biol (1975) 7.76
Complex splicing patterns of RNAs from the early regions of adenovirus-2. J Mol Biol (1979) 7.53
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature (1979) 6.60
Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site. Nature (1982) 5.61
Expression of early adenovirus genes requires a viral encoded acidic polypeptide. Proc Natl Acad Sci U S A (1981) 4.42
Host-range mutants of adenovirus type 5 defective for growth in HeLa cells. Virology (1977) 4.40
Mapping of late adenovirus genes by cell-free translation of RNA selected by hybridization to specific DNA fragments. Proc Natl Acad Sci U S A (1975) 4.35
Identification of the gene and mRNA for the adenovirus terminal protein precursor. Cell (1981) 3.39
The nucleotide sequence of the transforming HpaI-E fragment of adenovirus type 5 DNA. Gene (1978) 3.36
Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harb Symp Quant Biol (1980) 3.15
Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (1983) 2.96
Comparison of viral RNA sequences in adenovirus 2-transformed and lytically infected cells. J Mol Biol (1975) 2.95
Further mapping of late adenovirus genes by cell-free translation of RNA selected by hybridization to specific DNA fragments. Cell (1977) 2.78
The structure of adenovirus 2 early nuclear and cytoplasmic RNAs. J Mol Biol (1980) 2.74
Transformation-defective mutant of adenovirus type 5 containing a single altered E1a mRNA species. J Virol (1981) 2.57
Structure of two adenovirus type 12 transforming polypeptides and their evolutionary implications. Nature (1980) 2.38
The cytopathic effects of vervet monkey viruses. S Afr Med J (1963) 2.23
Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replication. Cell (1982) 2.22
Structure and gene organization in the transformed Hind III-G fragment of Ad12. Cell (1980) 2.22
Eukaryotic promoters? Nature (1979) 1.98
The nucleotide sequence of the transforming BglII-H fragment of adenovirus type 7 DNA. Gene (1980) 1.83
Splicing of adenovirus 2 early region 1A mRNAs is non-sequential. J Mol Biol (1983) 1.82
Expression of region E1b of human adenoviruses in the absence of region E1a is not sufficient for complete transformation. Virology (1983) 1.78
Transformation-deficient adenovirus mutant defective in expression of region 1A but not region 1B. J Virol (1982) 1.76
Establishment and characterization of rat cell lines transformed by restriction endonuclease fragments of adenovirus 12 DNA. Virology (1977) 1.71
Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses. Gene (1980) 1.68
Sequence analysis of adenovirus DNA. IV. The genomic sequences encoding the common tripartite leader of late adenovirus messenger RNA. J Mol Biol (1979) 1.55
Arrangement of messenger RNAs and protein coding sequences in the major late transcription unit of adenovirus 2. J Mol Biol (1980) 1.53
The relationship between region E1a and E1b of human adenoviruses in cell transformation. Gene (1982) 1.50
The molecular structure of the 9S mRNA from early region 1A of adenovirus serotype 2. J Mol Biol (1983) 1.46
Adenovirus transformation of hamster embryo cells. J Virol (1968) 1.44
The gene and messenger RNA for adenovirus polypeptide IX. Cell (1977) 1.34
Transcription of adenovirus RNA in permissive and nonpermissive infections. J Virol (1978) 1.26
Transformation of a rat cell line by an adenovirus 7 DNA fragment. Virology (1978) 1.18
Mapping of adenovirus 12 mRNA's transcribed from the transforming region. J Virol (1980) 1.09
Nucleotide sequences, integration, and transcription of the adenovirus-12 transforming genes. Cold Spring Harb Symp Quant Biol (1980) 0.99
Gene organization of the transforming region of weakly oncogenic adenovirus type 7: the E1a region. Gene (1980) 0.96
Comparison of the nucleotide sequences of early region E1b DNA of human adenovirus types 12, 7 and 5 (subgroups A, B and C). Gene (1983) 0.95
Retention of tumour-inducing capacity by adenovirus DNA after cleavage by restriction endonucleases. Nature (1975) 0.84
Tumour induction by simian adenovirus SA7 DNA fragments. Nat New Biol (1971) 0.83
Base composition of the DNA of oncogenic simian adenovirus SA7 and homology with human adenovirus DNA's. Virology (1968) 0.81
Mappings of adenovirus type 7 cytoplasmic RNA species synthesized early in lytically infected cells and synthesized in transformed cells. J Virol (1979) 0.81
[Simian adenovirus genome. II. Identification of specific fragments of viral DNA possessing transforming activity]. Mol Biol (Mosk) (1982) 0.79
Biological activity of the intact and cleaved DNA of the simian adenovirus 7. Nucleic Acids Res (1979) 0.79
Efficient translation of tobacco mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from commercial wheat germ. Proc Natl Acad Sci U S A (1973) 16.94
Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell (1984) 13.91
Purification and mapping of specific mRNAs by hybridization-selection and cell-free translation. Proc Natl Acad Sci U S A (1979) 9.94
The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev (1996) 7.78
Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation. Proc Natl Acad Sci U S A (1977) 7.46
Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell (2001) 5.19
ClinQuery: a system for online searching of data in a teaching hospital. Ann Intern Med (1989) 5.13
Simian virus 40 DNA directs synthesis of authentic viral polypeptides in a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1975) 4.98
Expression of early adenovirus genes requires a viral encoded acidic polypeptide. Proc Natl Acad Sci U S A (1981) 4.42
A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev (1997) 3.80
Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J (1999) 3.18
Cell-free translation of messenger RNA of simian virus 40: synthesis of the major capsid protein. Proc Natl Acad Sci U S A (1974) 3.04
Crystal structure of a beta-catenin/Tcf complex. Cell (2000) 2.93
Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci (2000) 2.70
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med (1987) 2.59
XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development (1999) 2.56
Arrangement of late RNAs transcribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment. J Virol (1984) 2.48
Establishment of the dorso-ventral axis in Xenopus embryos is presaged by early asymmetries in beta-catenin that are modulated by the Wnt signaling pathway. J Cell Biol (1997) 2.42
A homeobox gene essential for zebrafish notochord development. Nature (1995) 2.25
The events of the midblastula transition in Xenopus are regulated by changes in the cell cycle. Cell (1987) 2.22
Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3. Development (1995) 2.18
Direct biochemical mapping of eukaryotic viral DNA by means of a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1976) 2.17
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell (1998) 2.03
Vaccinia virus induces cellular mRNA degradation. J Virol (1983) 2.02
Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant (2011) 1.96
Methods utilizing cell-free protein-synthesizing systems for the identification of recombinant DNA molecules. Methods Enzymol (1983) 1.94
From cortical rotation to organizer gene expression: toward a molecular explanation of axis specification in Xenopus. Bioessays (1998) 1.91
Initial cash/asset ratio and asset prices: an experimental study. Proc Natl Acad Sci U S A (1998) 1.87
Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? Pharmacol Ther (2008) 1.85
Expression of the human fibroblast interferon gene in Escherichia coli. Proc Natl Acad Sci U S A (1980) 1.84
Translation and developmental regulation of RNA encoded by the eukaryotic transposable element copia. Proc Natl Acad Sci U S A (1980) 1.80
Molecular identification of spadetail: regulation of zebrafish trunk and tail mesoderm formation by T-box genes. Development (1998) 1.77
Malignant neoplasms following bone marrow transplantation. Blood (1996) 1.76
The history of public health and the modern state. Introduction. Clio Med (1994) 1.76
Protein synthesis and the viability of rye grains. Loss of activity of protein-synthesizing systems in vitro associated with a loss of viability. Biochem J (1973) 1.72
Transcriptional mapping of the DNA polymerase gene of vaccinia virus. J Virol (1984) 1.69
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69
Postoperative pain control after lumbar spine fusion. Patient-controlled analgesia versus continuous epidural analgesia. Spine (Phila Pa 1976) (1997) 1.65
Fluorescence of tryptophan dipeptides: correlations with the rotamer model. Biochemistry (1991) 1.64
Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol (2000) 1.63
Organization of six early transcripts synthesized from a vaccinia virus EcoRI DNA fragment. J Virol (1984) 1.62
Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant (2000) 1.62
Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus. J Virol (1984) 1.60
Fluorescence properties of pteridine nucleoside analogs as monomers and incorporated into oligonucleotides. Anal Biochem (1997) 1.57
Aetiologic factors in lymphoid malignancies: a case-control epidemiological study. Leuk Res (1984) 1.57
Induction of the Xenopus organizer: expression and regulation of Xnot, a novel FGF and activin-regulated homeo box gene. Genes Dev (1993) 1.56
Abdominal compartment syndrome after mesenteric revascularization. J Vasc Surg (2001) 1.56
Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry (1994) 1.53
Arrangement of messenger RNAs and protein coding sequences in the major late transcription unit of adenovirus 2. J Mol Biol (1980) 1.53
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med (2001) 1.51
Daily relaxation response breaks in a working population: I. Effects on self-reported measures of health, performance, and well-being. Am J Public Health (1977) 1.48
Computerized radiologic reporting with voice data-entry. Radiology (1981) 1.48
Activation of Siamois by the Wnt pathway. Dev Biol (1996) 1.47
Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Exp Hematol (1999) 1.47
The 3' noncoding region of beta-globin mRNA is not essential for in vitro translation. Nucleic Acids Res (1979) 1.46
A room-temperature molecular/organic-based magnet. Science (1991) 1.44
Effect of resistance training on single muscle fiber contractile function in older men. J Appl Physiol (1985) (2000) 1.43
Tobacco mosaic virus RNA directs the synthesis of a coat protein peptide in a cell-free system from wheat. J Mol Biol (1973) 1.43
Weak ferromagnetism in a three-dimensional manganese(II) azido complex, [Mn(4,4'-bipy)(N3)2]n (bipy = bipyridine). Inorg Chem (2000) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Delineation of the viral products of recombination in vaccinia virus-infected cells. J Virol (1988) 1.40
Evolution of T4-related phages. Virus Genes (1995) 1.39
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells. Blood (1998) 1.39
CT detection of cortical fracture of the femoral head associated with posterior hip dislocation. AJR Am J Roentgenol (1990) 1.38
Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression. J Virol (1985) 1.38
Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost (1989) 1.37
The cell-free synthesis and assembly of viral specific polypeptides into TMV particles. Virology (1974) 1.36
Tcf4 can specifically recognize beta-catenin using alternative conformations. Nat Struct Biol (2001) 1.35
Determination of actin messenger RNA in cultures of differentiating embryonic chick skeletal muscle. Proc Natl Acad Sci U S A (1974) 1.35
Processing of the Drosophila Sog protein creates a novel BMP inhibitory activity. Development (2000) 1.35
Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J Virol (1992) 1.34
Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. Proc Natl Acad Sci U S A (1984) 1.31
Comparing the rheology of native spider and silkworm spinning dope. Nat Mater (2006) 1.30
Energy expenditure during front crawl swimming: predicting success in middle-distance events. Int J Sports Med (1985) 1.30
Collection of a clean voided urine specimen: a comparison among spoken, written, and computer-based instructions. Am J Public Health (1977) 1.29
What was social medicine? An historiographical essay. J Hist Sociol (1988) 1.28
The homeobox genes vox and vent are redundant repressors of dorsal fates in zebrafish. Development (2001) 1.27
Calculation of protein tertiary structure. J Mol Biol (1976) 1.27
The politics of prevention: anti-vaccinationism and public health in nineteenth-century England. Med Hist (1988) 1.27
Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant (2011) 1.26
Identification of bidirectional promoters in the human KIR genes. Genes Immun (2007) 1.25
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Bone Marrow Transplant (2003) 1.22
Short-component multiple schedules: effects of relative reinforcement duration. J Exp Anal Behav (1975) 1.22
Resistance training improves single muscle fiber contractile function in older women. Am J Physiol Cell Physiol (2001) 1.22
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant (2009) 1.21
Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J Lipid Res (1981) 1.21
A fluorometric assay for DNA cleavage reactions characterized with BamHI restriction endonuclease. Anal Biochem (1994) 1.21
Profile of cognitive functioning in women with the fragile X mutation. Neuropsychology (2001) 1.20
Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J Infect Dis (1997) 1.20
Activin-mediated mesoderm induction requires FGF. Development (1994) 1.20
Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J Biol Chem (1996) 1.19
Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol (1988) 1.18
Intra-articular morphine and/or bupivacaine in the management of pain after total knee arthroplasty. J Arthroplasty (1997) 1.17
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.13